Impact of Hepatitis B Virus on Inflammatory Bowel Disease
Recruiting · NCT06881238 · Observational (researchers observe without assigning treatment) · Lead sponsor: Tanta University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients. Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection. Participants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.
Who can take part
Inclusion criteria
- Male or female patients older than 18 years.
- Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.
Exclusion criteria
- Patients aged \< 18 years
- Unwilling to participate in our study
Where it is running
1 location listed.
- Tanta University Hospitals - Tanta, Gharbyea, Egypt